Type one diabetes is not a widely understood condition. It’s an enigma in the way it materialises, and it’s an enigma to society, too. In many ways, type one diabetes is an invisible illness. It […]

Type one diabetes is not a widely understood condition. It’s an enigma in the way it materialises, and it’s an enigma to society, too. In many ways, type one diabetes is an invisible illness. It […]
A new diabetes research centre is to be opened at Oxford University by Danish pharmaceutical company Novo Nordisk. The company’s £115m investment and their promise of 10 years of continued funding comes in spite of […]